The country’s health surveillance agency ANVISA confirms the efficacy of Gelita’s Verisol for skin health, approving its local market use in food supplements.
Collagen supplements in Brazil that deliver a daily dose of 2.5g of the specific Bioactive Collagen Peptides Verisol from Gelita has been allowed to use skin health claims, under ANVISA’s new rules.
The announcement follows ANVISA’s introduction of specific regulations for food supplements in 2018, when manufacturers were called to prove the efficacy of their products. The framework was designed to reduce the information gap in the Brazilian market, especially related to marketing claims that lack specific scientific proof. The agency has been building a positive list of approved ingredients and health claims. Companies have a transition period to adapt existing products, while new products have to be within the scope of the new rules.
Verisol comprises collagen peptides that have been specifically developed to provide “the highest possible” efficacy in human skin. They stimulate fibroblast cells in the dermis which substantially increases the renewal and repair of collagen, elastin and proteoglycans – all of which are essential for providing skin elasticity. As a result, the epidermis is supported from within and skin sagging is prevented.
According to Gelita, the efficacy of Verisol “has been proven statistically significant in six different studies specific to the product”, involving nearly 500 participants. Here, their effect on skin elasticity, wrinkles, fine lines, cellulite, nails and hair was researched and confirmed.
Verisol, as well as all of Gelita’s Bioactive Collagen Peptides, is soluble and can be incorporated into various types of liquid and solid functional food applications or nutricosmetics – from drinks and concentrated ready-to-consume liquid shots to tablets, capsules and flavoured powder mixes. The company’s Bioactive Collagen Peptides are digestible as well as bioavailable.